About Astal Laboratories Limited
Data last updated: 06 January 2026
Astal Laboratories Limited is a public limited company based in Noida, Uttar Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 03 August 1993, the company has been in operation for over 33 years.
Registered with ROC Kanpur under CIN L74120UP1993PLC015605. Listed on BSE: 512600.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹10.77 Cr. Formerly known as Macro (International) Exports Limited. It is led by directors including Ravikanti Shailaja and Hemachakrapani Bangaraiahgari.
Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: Office No. B7 A – 40 Sector 4, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.36 Cr, reflecting significant growth compared to the previous year.
The company is associated with 1 brand - Macro International. As per MCA filings, the company has open charges of ₹14.1 Cr and satisfied charges of ₹2.46 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website miel.co.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressOffice No. B7 A – 40 Sector 4, Noida, Uttar Pradesh, India – 201301
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Astal Laboratories Limited
Astal Laboratories Limited has one previous CIN (Corporate Identification Number): L16001UP1993PLC015605. The current CIN is L74120UP1993PLC015605, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74120UP1993PLC015605 | Current |
| L16001UP1993PLC015605 | Previous |
Associated Brands with Astal Laboratories Limited
Astal Laboratories Limited operates one associated brand: Macro International. These brands represent Astal Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Multiple real estate strategies are focused on by the firm. | miel.co.in |
Business Activity of Astal Laboratories Limited
Astal Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Astal Laboratories Limited
Astal Laboratories Limited is audited by M/s Sathuluri & Co. (ICAI peer reviewed, certificate valid till 2027-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s Sathuluri & Co. (ICAI peer reviewed, certificate valid till 2027-10-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Astal Laboratories Limited
Astal Laboratories Limited is currently managed by 9 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravikanti Shailaja | Director | 08 Sep 2022 | 3 Years 10 Months | Current |
|
Hemachakrapani Bangaraiahgari
Also directs:
Astal Laboratories Limited
|
Director | 08 Sep 2022 | 3 Years 10 Months | Current |
|
Birendrakumar Sahoo
Also directs:
Astal Laboratories Limited, Anand Life Sciences Llp, Manoharamma Hotel Investments Private Limited and 4 more
|
Director | 24 May 2024 | 2 Years 1 Months | Current |
| Maggidi Venkatesh | Director | 10 Jun 2023 | 3 Years 0 Months | Current |
| Sudheer Karna Kankanala | Whole-Time Director | 08 Sep 2022 | 3 Years 10 Months | Current |
| Balayogiswara Rao Peddinti | Cfo | 15 Jul 2023 | 2 Years 11 Months | Current |
Financials of Astal Laboratories Limited FY 2026 filings available
Astal Laboratories Limited reported revenue of ₹249.13 Cr (up ) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 |
|---|---|
| Revenue from Operations | ₹249.13 Cr |
| Other Income | ₹22.15 Lakh |
| Total Income | ₹249.35 Cr |
| Cost of Materials Consumed | ₹224.91 Cr |
| Purchases of Stock-in-Trade | ₹0 |
| Changes in Inventories | -₹5.89 Cr |
| Employee Benefit Expense | ₹5.02 Cr |
| Finance Costs | ₹2.03 Cr |
| Depreciation & Amortisation | ₹1.23 Cr |
| Other Expenses | ₹4.32 Cr |
| Total Expenses | ₹231.62 Cr |
| Profit Before Exceptional Items & Tax | ₹17.73 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | ₹17.73 Cr |
| Total Tax Expense | ₹3.02 Cr |
| Net Profit | ₹14.71 Cr |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | ₹14.71 Cr |
| EBITDA (computed) | ₹20.99 Cr |
| Basic EPS | ₹8.62 |
| Diluted EPS | ₹7.81 |
| Metrics | FY 2026 |
|---|---|
| Total Assets | ₹518.19 Cr |
| Non-current Assets | ₹274.7 Cr |
| Current Assets | ₹243.5 Cr |
| Property, Plant & Equipment | ₹63.71 Cr |
| Inventories | ₹67.52 Cr |
| Trade Receivables | ₹156.35 Cr |
| Cash & Equivalents | ₹1.3 Cr |
| Equity (Net Worth) | ₹333.76 Cr |
| Equity Share Capital | ₹42.23 Cr |
| Borrowings (Non-current) | ₹18.64 Cr |
| Borrowings (Current) | ₹30.44 Cr |
| Total Debt (computed) | ₹49.08 Cr |
| Current Liabilities | ₹164.29 Cr |
| Total Liabilities | ₹184.44 Cr |
| Metrics | FY 2026 |
|---|---|
| Operating Cash Flow | -₹17.7 Cr |
| Investing Cash Flow | -₹2.17 Cr |
| Financing Cash Flow | ₹2.58 Cr |
| Capital Expenditure | ₹1.39 Cr |
| Free Cash Flow (computed) | -₹19.09 Cr |
| Dividends Paid | ₹0 |
| Net Change in Cash | -₹17.29 Cr |
| Metrics | Q4 FY26 |
|---|---|
| Revenue from Operations | ₹134.05 Cr |
| Other Income | ₹9.62 Lakh |
| Total Income | ₹134.15 Cr |
| Cost of Materials Consumed | ₹108.25 Cr |
| Purchases of Stock-in-Trade | ₹0 |
| Changes in Inventories | ₹9.36 Cr |
| Employee Benefit Expense | ₹3.72 Cr |
| Finance Costs | ₹1.09 Cr |
| Depreciation & Amortisation | ₹86.08 Lakh |
| Other Expenses | ₹2.53 Cr |
| Total Expenses | ₹125.81 Cr |
| Profit Before Exceptional Items & Tax | ₹8.34 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | ₹8.34 Cr |
| Total Tax Expense | ₹65.66 Lakh |
| Net Profit | ₹7.68 Cr |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | ₹7.68 Cr |
| EBITDA (computed) | ₹10.29 Cr |
| Basic EPS | ₹2.04 |
| Diluted EPS | ₹1.95 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹156 Cr | ₹64.23 Cr | ₹23.65 Cr | ₹3.43 Cr | ₹0 | ₹20.31 Lakh | ₹0 | ₹0 |
| Other Income | ₹19.15 Lakh | ₹12.51 Lakh | ₹1.34 Lakh | ₹17.87 Lakh | ₹21.08 Lakh | ₹0 | ₹20.48 Lakh | ₹30.04 Lakh |
| Total Income | ₹156.19 Cr | ₹64.36 Cr | ₹23.66 Cr | ₹3.61 Cr | ₹21.08 Lakh | ₹20.31 Lakh | ₹20.48 Lakh | ₹30.04 Lakh |
| Cost of Materials Consumed | ₹152.88 Cr | ₹61.81 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹22.4 Cr | ₹3.35 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹14.02 Cr | -₹13.7 Cr | -₹1.06 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹2.11 Cr | ₹1.34 Cr | ₹46.57 Lakh | ₹6.48 Lakh | ₹8.52 Lakh | ₹6.19 Lakh | ₹9.48 Lakh | ₹7.09 Lakh |
| Finance Costs | ₹1.41 Cr | ₹70.07 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹68.84 Lakh | ₹22.31 Lakh | ₹2.95 Lakh | ₹79,000 | ₹1.45 Lakh | ₹1.55 Lakh | ₹1.55 Lakh | ₹1.58 Lakh |
| Other Expenses | ₹2.24 Cr | ₹2 Cr | ₹74.05 Lakh | ₹14.74 Lakh | ₹12.81 Lakh | ₹11.76 Lakh | ₹12.26 Lakh | ₹28.91 Lakh |
| Total Expenses | ₹145.32 Cr | ₹52.38 Cr | ₹22.57 Cr | ₹3.57 Cr | ₹22.78 Lakh | ₹19.5 Lakh | ₹23.29 Lakh | ₹37.58 Lakh |
| Profit Before Exceptional Items & Tax | ₹10.87 Cr | ₹11.98 Cr | ₹1.09 Cr | ₹3.21 Lakh | -₹1.7 Lakh | ₹81,000 | -₹2.81 Lakh | -₹7.54 Lakh |
| Exceptional Items | ₹0 | -₹1,000 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10.87 Cr | ₹11.98 Cr | ₹1.09 Cr | ₹3.21 Lakh | -₹1.7 Lakh | ₹81,000 | -₹2.81 Lakh | -₹7.54 Lakh |
| Total Tax Expense | ₹2.75 Cr | ₹3.05 Cr | ₹30.19 Lakh | ₹1.57 Lakh | ₹1,000 | ₹21,000 | ₹1,000 | ₹67,000 |
| Net Profit | ₹8.12 Cr | ₹8.93 Cr | ₹78.47 Lakh | ₹1.64 Lakh | -₹1.71 Lakh | ₹60,000 | -₹2.82 Lakh | -₹8.21 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹8.12 Cr | ₹8.93 Cr | ₹78.47 Lakh | ₹1.64 Lakh | -₹1.71 Lakh | ₹60,000 | -₹2.82 Lakh | -₹8.21 Lakh |
| EBITDA (computed) | ₹12.96 Cr | ₹12.9 Cr | ₹1.12 Cr | ₹4 Lakh | -₹25,000 | ₹2.36 Lakh | -₹1.26 Lakh | -₹5.96 Lakh |
| Basic EPS | ₹4.76 | ₹9.08 | ₹1.55 | ₹0.04 | ₹0.00 | ₹0.02 | ₹0.00 | ₹0.00 |
| Diluted EPS | ₹4.31 | ₹8.04 | ₹1.55 | ₹0.04 | ₹0.00 | ₹0.02 | ₹0.00 | ₹0.00 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹399.57 Cr | ₹63.34 Cr | ₹36.61 Cr | ₹9.91 Cr | ₹5.23 Cr | ₹5.31 Cr | ₹5.27 Cr | ₹5.33 Cr |
| Non-current Assets | ₹296.31 Cr | ₹17.7 Cr | ₹9.89 Cr | ₹3.79 Cr | ₹8.23 Lakh | ₹6.01 Lakh | ₹14.06 Lakh | ₹15.61 Lakh |
| Current Assets | ₹103.26 Cr | ₹45.64 Cr | ₹26.73 Cr | ₹6.11 Cr | ₹5.15 Cr | ₹5.25 Cr | ₹5.13 Cr | ₹5.17 Cr |
| Property, Plant & Equipment | ₹11.36 Cr | ₹11.44 Cr | ₹69 Lakh | ₹56,000 | ₹1.35 Lakh | ₹0 | ₹6.86 Lakh | ₹8.41 Lakh |
| Inventories | ₹28.78 Cr | ₹14.76 Cr | ₹1.06 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Trade Receivables | ₹72.3 Cr | ₹27.66 Cr | ₹15.82 Cr | ₹3.17 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Cash & Equivalents | ₹69.6 Lakh | ₹1.73 Cr | ₹6.08 Cr | ₹8.44 Lakh | ₹1.83 Lakh | ₹3.13 Lakh | ₹1.45 Lakh | ₹82,000 |
| Equity (Net Worth) | ₹327.16 Cr | ₹35.99 Cr | ₹23.34 Cr | ₹5.18 Cr | ₹5.16 Cr | ₹5.18 Cr | ₹5.17 Cr | ₹5.2 Cr |
| Equity Share Capital | ₹42.23 Cr | ₹9.85 Cr | ₹9.85 Cr | ₹3.99 Cr | ₹3.99 Cr | ₹3.99 Cr | ₹3.99 Cr | ₹3.99 Cr |
| Borrowings (Non-current) | ₹36.59 Lakh | ₹45.61 Lakh | ₹25.74 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹11.59 Cr | ₹12.81 Cr | ₹5.48 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹11.96 Cr | ₹13.27 Cr | ₹31.22 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹71.11 Cr | ₹26.77 Cr | ₹13.01 Cr | ₹4.73 Cr | ₹6.89 Lakh | ₹13.16 Lakh | ₹7.72 Lakh | ₹13.25 Lakh |
| Total Liabilities | ₹72.41 Cr | ₹27.35 Cr | ₹13.27 Cr | ₹4.73 Cr | ₹6.89 Lakh | ₹13.16 Lakh | ₹10.08 Lakh | ₹13.25 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹3.08 Cr | -₹12.52 Cr | -₹5.59 Cr | -₹1.44 Cr | -₹24.87 Lakh |
| Investing Cash Flow | -₹1.28 Cr | -₹7.81 Cr | -₹6.12 Cr | ₹17.87 Lakh | ₹23.58 Lakh |
| Financing Cash Flow | ₹4.55 Cr | ₹3.29 Cr | ₹17.7 Cr | ₹1.32 Cr | ₹0 |
| Capital Expenditure | ₹40.72 Lakh | ₹0 | ₹71.39 Lakh | ₹0 | ₹0 |
| Free Cash Flow (computed) | -₹3.48 Cr | -₹12.52 Cr | -₹6.3 Cr | -₹1.44 Cr | -₹24.87 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹18.63 Lakh | -₹17.04 Cr | ₹5.99 Cr | ₹6.61 Lakh | -₹1.29 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹40.92 Cr | ₹52.24 Cr | ₹37.52 Cr | ₹25.33 Cr | ₹23.47 Cr | ₹14.46 Cr | ₹13.16 Cr | ₹13.15 Cr |
| Other Income | ₹6.62 Lakh | ₹3.65 Lakh | ₹3.27 Lakh | ₹5.61 Lakh | ₹3.5 Lakh | ₹5.59 Lakh | ₹0 | ₹3.42 Lakh |
| Total Income | ₹40.98 Cr | ₹52.27 Cr | ₹37.55 Cr | ₹25.38 Cr | ₹23.5 Cr | ₹14.51 Cr | ₹13.16 Cr | ₹13.18 Cr |
| Cost of Materials Consumed | ₹36.23 Cr | ₹54.49 Cr | ₹39.08 Cr | ₹23.08 Cr | ₹24.84 Cr | ₹12.28 Cr | ₹13.1 Cr | ₹11.59 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹1.23 Cr | -₹7.37 Cr | -₹6.26 Cr | -₹1.62 Cr | -₹6.49 Cr | -₹1.94 Cr | -₹3.6 Cr | -₹1.66 Cr |
| Employee Benefit Expense | ₹80.72 Lakh | ₹44 Lakh | ₹41.83 Lakh | ₹44.72 Lakh | ₹9.08 Lakh | ₹40.67 Lakh | ₹43.34 Lakh | ₹40.76 Lakh |
| Finance Costs | ₹46.72 Lakh | ₹33.21 Lakh | ₹30.91 Lakh | ₹30.08 Lakh | ₹26.58 Lakh | ₹28.08 Lakh | ₹9.13 Lakh | ₹6.29 Lakh |
| Depreciation & Amortisation | ₹32.1 Lakh | ₹12.48 Lakh | ₹12.24 Lakh | ₹12.01 Lakh | ₹10.41 Lakh | ₹8.13 Lakh | ₹2.5 Lakh | ₹1.28 Lakh |
| Other Expenses | ₹46.01 Lakh | ₹1.12 Cr | ₹40.95 Lakh | ₹25.59 Lakh | ₹83.95 Lakh | ₹39.57 Lakh | ₹34 Lakh | ₹42.9 Lakh |
| Total Expenses | ₹39.51 Cr | ₹49.14 Cr | ₹34.08 Cr | ₹22.59 Cr | ₹19.65 Cr | ₹11.5 Cr | ₹10.39 Cr | ₹10.84 Cr |
| Profit Before Exceptional Items & Tax | ₹1.47 Cr | ₹3.13 Cr | ₹3.47 Cr | ₹2.79 Cr | ₹3.85 Cr | ₹3.02 Cr | ₹2.77 Cr | ₹2.34 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1,000 | ₹0 | ₹0 |
| Profit Before Tax | ₹1.47 Cr | ₹3.13 Cr | ₹3.47 Cr | ₹2.79 Cr | ₹3.85 Cr | ₹3.02 Cr | ₹2.77 Cr | ₹2.34 Cr |
| Total Tax Expense | ₹38.59 Lakh | ₹77.37 Lakh | ₹88.73 Lakh | ₹70.32 Lakh | ₹1.1 Cr | ₹52.93 Lakh | ₹76.98 Lakh | ₹64.93 Lakh |
| Net Profit | ₹1.09 Cr | ₹2.36 Cr | ₹2.58 Cr | ₹2.09 Cr | ₹2.74 Cr | ₹2.49 Cr | ₹2 Cr | ₹1.69 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹1.09 Cr | ₹2.36 Cr | ₹2.58 Cr | ₹2.09 Cr | ₹2.74 Cr | ₹2.49 Cr | ₹2 Cr | ₹1.69 Cr |
| EBITDA (computed) | ₹2.26 Cr | ₹3.59 Cr | ₹3.9 Cr | ₹3.21 Cr | ₹4.22 Cr | ₹3.38 Cr | ₹2.89 Cr | ₹2.41 Cr |
| Basic EPS | ₹0.29 | ₹2.19 | ₹2.40 | ₹2.12 | ₹2.80 | ₹2.53 | ₹2.04 | ₹1.72 |
| Diluted EPS | ₹0.27 | ₹1.74 | ₹1.97 | ₹1.73 | ₹1.76 | ₹2.53 | ₹2.04 | ₹1.72 |
Shareholding Pattern of Astal Laboratories Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 4.70%, retail and other public shareholders hold 95.30% of Astal Laboratories Limited. The company had 3,065 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 4.70% | 18.19% | 18.19% | 19.93% | 19.93% | 19.93% |
| Public | 95.30% | 81.81% | 81.81% | 80.07% | 80.07% | 80.07% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 4.70% | 19.93% | 19.93% |
| Public | 95.30% | 80.07% | 80.07% |
| Promoter change (YoY, %pts) | -15.23 | +0.00 | - |
Charges & Borrowings of Astal Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Nov 2024 | Canara Bank | ₹9 Cr | Open |
| 25 Apr 2024 | Canara Bank | ₹5.1 Cr | Open |
| 29 Sep 1997 | Canara Bank | ₹10 Lakh | Satisfied |
| 29 Sep 1997 | Canara Bank | ₹10 Lakh | Satisfied |
| 13 Mar 1996 | Canara Bank | ₹82 Lakh | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Astal Laboratories Limited
View historical data on people associated with Astal Laboratories Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Astal Laboratories Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Astal Laboratories Limited
GSTIN & GST Filing Data of Astal Laboratories Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Astal Laboratories Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Astal Laboratories Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Astal Laboratories Limited
MSME Payment Delays by Astal Laboratories Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Astal Laboratories Limited
Subsidiaries & Group Companies of Astal Laboratories Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Astal Laboratories Limited with ownership details.
MCA Filings & Documents of Astal Laboratories Limited
MCA Filings & Documents of Astal Laboratories Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Astal Laboratories Limited
Frequently Asked Questions about Astal Laboratories Limited
Astal Laboratories Limited is an active public limited company in the pharma sector based in Noida, Uttar Pradesh, India. It was incorporated on 03 August 1993 (33+ years old) and is registered under CIN L74120UP1993PLC015605. Listed on BSE: 512600.
Astal Laboratories Limited reported revenue of ₹64.36 Cr for FY 2025 (up 172.00% YoY).
The current directors of Astal Laboratories Limited are:
- Balayogiswara Rao Peddinti
- Ravikanti Shailaja
- Hemachakrapani Bangaraiahgari
- Birendrakumar Sahoo
- Mahendra Kumar
- Maggidi Venkatesh
- Sudheer Karna Kankanala
- Radhakishore Pandrangi
- Julius Paul Reinhard Paschke
The primary industry of Astal Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Astal Laboratories Limited is listed on BSE with code 512600.
Astal Laboratories Limited can be reached at the registered office: Office No. B7 A – 40 Sector 4, Noida, Uttar Pradesh, India – 201301, or through the website miel.co.in.